TITLE

Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer

AUTHOR(S)
Vather, Ryash; Sammour, Tarik; Zargar-Shoshtari, Kamran; Metcalf, Patricia; Connolly, Andrew; Hill, Andrew
PUB. DATE
March 2009
SOURCE
International Journal of Colorectal Disease;Mar2009, Vol. 24 Issue 3, p283
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Mortality from cancer recurrence in Dukes B patients is approximately 25–30%. Outcome in Dukes B patients improves in direct relation to the number of lymph nodes examined. Examining fewer lymph nodes risks understaging and also such patients are less likely to receive chemotherapy. The aim of this study was to assess the impact of the number of lymph nodes examined on recurrence and mortality in Dukes B colon cancers. A retrospective database was constructed of 328 consecutive patients who underwent resection for Dukes B colorectal cancer between January 1993 and December 2001 at Middlemore Hospital. Patients with incomplete data, previous colorectal cancer, or perioperative deaths were excluded as were cases of rectal cancer. Data for the remaining 216 patients was subjected to multivariate and logistic regression analysis with ‘patient death’ or ‘cancer recurrence’ (CRec5) within 5 years as endpoints. A graph was constructed depicting CRec5 as broken down by lymph node strata. Receiver operator characteristic (ROC) curves were constructed for mortality and CRec5. The mean number of lymph nodes examined was 16.0 (median 14; range 2–48). The mean number of lymph nodes examined in those who died within 5 years was 12.8 vs. 17.5 in those who remained alive ( p = 0.0027). The mean number of lymph nodes examined in those with evidence of recurrence within 5 years was 11.8 vs. 17.1 in those without recurrence ( p = 0.0007). Analysis at various lymph node strata showed a sharp and statistically significant drop in the recurrence rate after the 16the node mark. The ROC curve for CRec5 showed that examination of 12 lymph nodes provided maximum sensitivity (0.60) and specificity (0.64). Examination of more than 16 lymph nodes is associated with a significant reduction in cancer recurrence. This supports the current clinical practice of harvesting and analysing as many nodes as possible during surgical resection and pathological analysis.
ACCESSION #
36296244

 

Related Articles

  • Adequate lymph node examination is essential to ensure the prognostic value of the lymph node ratio in patients with stage III colorectal cancer. Shimomura, Manabu; Ikeda, Satoshi; Takakura, Yuji; Kawaguchi, Yasuo; Tokunaga, Masakazu; Egi, Hiroyuki; Hinoi, Takao; Okajima, Masazumi; Ohdan, Hideki // Surgery Today;Oct2011, Vol. 41 Issue 10, p1370 

    Purpose: This study aimed to assess the prognostic value of the lymph node ratio (LNR), estimated by dividing the number of positive lymph nodes (LNs) by the number of LNs examined, for stage III colorectal cancer in comparison to the new tumor, nodes, and metastasis (TNM) system, and to...

  • Colon Cancer Recurrence Score Validated as a Useful Clinical Tool.  // MD Conference Express;Jul2009, p8 

    The article reports on the study that develops and validates a gene-based Recurrence Score to predict recurrence in patients with stage II colon cancer who have undergone surgery. The validation study shows a significant relationship between the continuous Recurrence Score and the likelihood of...

  • Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer. Sasaki, Kazuhito; Kawasaki, Hiroshi; Sato, Motohiro; Koyama, Ken; Yoshimi, Fuyo; Nagai, Hideo // Digestive Surgery;Nov2016, Vol. 34 Issue 1, p60 

    Background/Aims: Although the diagnostic value of fluorine-18 2-fluoro-2-deoxy-D-glucose (F-18-FDG) positron emission tomography/computed tomography (F-18-FDGPET/ CT) in patients with colorectal cancer (CRC) has been reported, the association between the F-18-FDG uptake in metastatic lymph nodes...

  • Up-Regulation of MicroRNA-145 Associates with Lymph Node Metastasis in Colorectal Cancer. Yuan, Wei; Sui, Chenguang; Liu, Qian; Tang, Wanyan; An, Huaying; Ma, Jie // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Metastasis is the main cause of mortality in patients with solid tumours. Identifying the exact molecules associated with CRC metastasis may be crucial to understand the process, which might also be translated to the diagnosis and treatment of CRC. In this study, we investigate the association...

  • Challenges in Staging Systems for Colorectal Cancer: Clinical Significance of Metastatic Lymph Node Number in Colorectal Cancer and Mesorectal Extension in Rectal Cancer. Akagi, Yoshito; Fukushima, Takanaru; Mizobe, Tomoaki; Shiratsuchi, Ichitaro; Ryu, Yasuhiko; Yoshida, Takefumi; Ishibashi, Nobuya; Tetsushi, Kinugasa; Shirouzu, Kazuo // Digestion;2010, Vol. 82 Issue 3, p192 

    In many countries, treatment for cancer is performed based on staging systems in which the degree of cancer development is defined objectively. A common staging system is thus needed to compare outcomes. The staging system for colorectal cancer in Japan has been made to enhance consistency with...

  • Danish Colorectal Cancer Group Database. Ingeholm, Peter; Gögenur, Ismail; Iversen, Lene H. // Clinical Epidemiology;Oct2016, Vol. 8, p465 

    Aim of database: The aim of the database, which has existed for registration of all patients with colorectal cancer in Denmark since 2001, is to improve the prognosis for this patient group. Study population: All Danish patients with newly diagnosed colorectal cancer who are either diagnosed or...

  • New Analysis Gives Cancer Patients Personalized Prognosis.  // Ascribe Newswire: Medicine;4/27/2004, p107 

    Researchers at Duke University have developed a new analytical approach that combines genetic and clinical data to give cancer patients an individualized prognosis of their cancer recurrence. While the Duke study focused on patients with breast cancer, the approach is applicable more broadly to...

  • The risk to develop a recurrence of a gastric cancer—is it independent of time? Klinge, Uwe; Ackermann, Diana; Lynen-Jansen, Petra; Mertens, Peter R. // Langenbeck's Archives of Surgery;Apr2008, Vol. 393 Issue 2, p149 

    Recurrence is the main reason for early death of cancer patients. Therefore, survival curves are regarded as crucial tools for clinicians to evaluate therapies and to estimate the patients’ prognosis. Current models for the development of recurrence are based on the assumption of a...

  • Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection. Tada, Takuhito; Fukuda, Haruyuki; Nakagawa, Katsuhiro; Matsui, Kaoru; Hosono, Masako; Takada, Yoshie; Inoue, Yuichi // International Journal of Clinical Oncology;Dec2005, Vol. 10 Issue 6, p425 

    Background. We investigated patterns of failure after radical radiation therapy in relation to the radiation field in patients with postsurgical locoregional recurrence of non-small cell lung cancer. Methods. Between 1992 and 2002, 31 patients with locoregional recurrence were treated with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics